The Acrodose PL System is a closed system for the pre-storage pooling and storage of leukoreduced Whole Blood-Derived Platelets (WBDP).
The Acrodose PLus System is a closed system for the pre-storage pooling, filtration and storage of non-leukoreduced WBDP.
Indication
Pooling, filtration (Acrodose PLus System only) and storage of platelets.
Blood Components Produced
Acrodose Platelets – ‘Transfusion-ready’, pooled,leukoreduced, and ABO matched platelets
Performance
An Acrodose Platelet—Addressing the Challenges of
Platelet Supply, Safety and Cost
With Acrodose Systems, a new generation platelet product, an Acrodose Platelet,
is produced meeting all these challenges. This innovative product is designed to be
clinically equivalent to single donor platelet (SDP) enabling blood collection facilities to
tap into the abundant but often discarded resource of whole blood-derived platelets.
In comparing whole blood-derived platelets to single donor platelets, consider:
Platelet Quality
In vitro and in vivo studies suggest that pooled, stored, ABO matched platelets
are comparable in quality to single donor platelets.1
Platelet Dosing
Acrodose Platelets can easily be targeted to consistently meet single donor platelet
counts (at least 3.0 x 1011 platelets in a dose).
Donor Exposure
Although the concern over donor exposure to viruses during pre-storage pooling is real,
the advent of nucleic acid testing (NAT) has significantly reduced this risk.2